Patents by Inventor Elliott C. Lasser

Elliott C. Lasser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180360784
    Abstract: Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers.
    Type: Application
    Filed: August 22, 2018
    Publication date: December 20, 2018
    Inventor: Elliott C. LASSER
  • Patent number: 9724317
    Abstract: Embodiments of the invention relate to methods and compositions for treating symptoms related to inflammatory conditions and to methods and compositions for treating inflammatory components of a common cold, utilizing various methods of administration od X-ray contrast media (CM).
    Type: Grant
    Filed: January 22, 2016
    Date of Patent: August 8, 2017
    Assignee: 3E Therapeutics Corporation
    Inventors: Elliott C. Lasser, Kenneth H. Lasser
  • Publication number: 20160136118
    Abstract: Embodiments of the invention relate to methods and compositions for treating symptoms related to inflammatory conditions and to methods and compositions for treating inflammatory components of a common cold, utilizing various methods of administration od X-ray contrast media (CM).
    Type: Application
    Filed: January 22, 2016
    Publication date: May 19, 2016
    Inventors: Elliott C. LASSER, Kenneth H. LASSER
  • Publication number: 20160106692
    Abstract: Embodiments disclosed herein relate to certain compositions including X-ray contrast media compounds and/or certain tri-iodinated phenyl compounds and methods of using the same for preventing or treating filovirus infections.
    Type: Application
    Filed: October 5, 2015
    Publication date: April 21, 2016
    Inventors: Elliott C. Lasser, Jesus Ernesto Villafranca, Erik S. Viirre
  • Patent number: 9241919
    Abstract: Embodiments of the invention relate to methods and compositions for treating symptoms related to inflammatory conditions and to methods and compositions for treating inflammatory components of common cold, utilizing various method of administration of X-ray contrast media (CM).
    Type: Grant
    Filed: April 18, 2013
    Date of Patent: January 26, 2016
    Assignee: 3E THERAPEUTICS CORPORATION
    Inventors: Elliott C. Lasser, Kenneth H. Lasser
  • Publication number: 20150290158
    Abstract: Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers.
    Type: Application
    Filed: November 7, 2013
    Publication date: October 15, 2015
    Inventor: Elliott C. LASSER
  • Publication number: 20150258049
    Abstract: Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers.
    Type: Application
    Filed: June 1, 2015
    Publication date: September 17, 2015
    Inventor: Elliott C. Lasser
  • Publication number: 20150209313
    Abstract: Embodiments disclosed herein relate to certain compositions including X-ray contrast media compounds and/or certain tri-iodated phenyl compounds and methods of using the same for preventing or treating influenza infections.
    Type: Application
    Filed: January 29, 2015
    Publication date: July 30, 2015
    Inventor: Elliott C. Lasser
  • Patent number: 9044448
    Abstract: Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: June 2, 2015
    Assignee: 3E THERAPEUTICS CORPORATION
    Inventor: Elliott C. Lasser
  • Patent number: 9044449
    Abstract: Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers.
    Type: Grant
    Filed: May 7, 2013
    Date of Patent: June 2, 2015
    Assignee: 3E THERAPEUTICS CORPORATION
    Inventor: Elliott C. Lasser
  • Publication number: 20140079810
    Abstract: Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers.
    Type: Application
    Filed: May 6, 2013
    Publication date: March 20, 2014
    Inventor: Elliott C. Lasser
  • Publication number: 20140079811
    Abstract: Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers.
    Type: Application
    Filed: May 7, 2013
    Publication date: March 20, 2014
    Inventor: Elliott C. Lasser
  • Publication number: 20130237604
    Abstract: Embodiments of the invention relate to methods and compositions for treating symptoms related to inflammatory conditions and to methods and compositions for treating inflammatory components of common cold, utilizing various method of administration of X-ray contrast media (CM).
    Type: Application
    Filed: April 18, 2013
    Publication date: September 12, 2013
    Applicant: Lasser Family Partnership, L.P.
    Inventors: Elliott C. Lasser, Kenneth H. Lasser
  • Publication number: 20130071490
    Abstract: Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers.
    Type: Application
    Filed: November 18, 2011
    Publication date: March 21, 2013
    Inventor: Elliott C. Lasser
  • Publication number: 20130071335
    Abstract: Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers.
    Type: Application
    Filed: September 20, 2011
    Publication date: March 21, 2013
    Inventor: Elliott C. Lasser
  • Publication number: 20110027193
    Abstract: Embodiments of the invention relate to methods and compositions for treating symptoms related to inflammatory conditions and to methods and compositions for treating inflammatory components of common cold, utilizing various method of administration of X-ray contrast media (CM).
    Type: Application
    Filed: October 12, 2010
    Publication date: February 3, 2011
    Applicant: Lasser Family Partnership, L.P.
    Inventors: Elliott C. Lasser, Kenneth H. Lasser
  • Patent number: 7838557
    Abstract: The present application is directed to the use of X-ray contrast media that act as universal antigens that are labeled herein as “pseudoantigens.” X-ray contrast media have the potential to exist in an aggregated state that is greater in increased concentrations. In this aggregated state, contrast media assume the role of multivalent antigens and can successfully compete with any other antigens involved in antibody-antigen reactions that lead to anaphylaxis. In this competition, the large quantity of contrast media serves to inhibit the adverse effects of antibody-antigen reactions without the contrast media itself creating antibodies or creating toxicity problems.
    Type: Grant
    Filed: December 18, 2006
    Date of Patent: November 23, 2010
    Assignee: Lasser Family Partnership, L.P.
    Inventor: Elliott C. Lasser
  • Publication number: 20080275128
    Abstract: Embodiments of the invention relate to methods and compositions for treating symptoms related to inflammatory conditions and to methods and compositions for treating inflammatory components of common cold, utilizing various method of administration of X-ray contrast media (CM).
    Type: Application
    Filed: April 28, 2008
    Publication date: November 6, 2008
    Inventors: Elliott C Lasser, Kenneth H. Lasser
  • Patent number: 7151117
    Abstract: The present application is directed to the use of X-ray contrast media that act as universal antigens that are labeled herein as “pseudoantigens.” X-ray contrast media have the potential to exist in an aggregated state that is greater in increased concentrations. In this aggregated state, contrast media assume the role of multivalent antigens and can successfully compete with any other antigens involved in antibody-antigen reactions that lead to anaphylaxis. In this competition, the large quantity of contrast media serves to inhibit the adverse effects of antibody-antigen reactions without the contrast media itself creating antibodies or creating toxicity problems.
    Type: Grant
    Filed: September 1, 2005
    Date of Patent: December 19, 2006
    Inventor: Elliott C. Lasser
  • Patent number: 6951641
    Abstract: The present application is directed to the use of X-ray contrast media that act as universal antigens that are labeled herein as “pseudoantigens.” X-ray contrast media have the potential to exist in an aggregated state that is greater in increased concentrations. In this aggregated state, contrast media assume the role of multivalent antigens and can successfully compete with any other antigens involved in antibody-antigen reactions that lead to anaphylaxis. In this competition, the large quantity of contrast media serves to inhibit the adverse effects of antibody-antigen reactions without the contrast media itself creating antibodies or creating toxicity problems.
    Type: Grant
    Filed: April 9, 2004
    Date of Patent: October 4, 2005
    Inventor: Elliott C. Lasser